Wehr, Germany

Mathias Scheer

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Develco Pharma Schweiz Ag, Kremers Urban Pharmaceuticals, Inc`. Active years: 2014-2016.

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Mathias Scheer

Introduction

Mathias Scheer, an accomplished inventor based in Wehr, Germany, has made notable contributions to the field of pharmaceutical formulations. With two patents to his name, he has developed innovative solutions aimed at improving medication delivery and effectiveness.

Latest Patents

Scheer's latest patents include a "Controlled Release Oral Dosage Form Comprising Oxycodone," which pertains to a method for administering oxycodone in a controlled-release format designed for once-a-day dosage. This innovation presents significant advantages for chronic pain management, enhancing patient compliance and therapeutic outcomes. Additionally, he holds a patent for a "Pharmaceutical Dosage Form," which relates to an oral pharmaceutical formulation for methylphenidate and its various analogs, derivatives, isomers, or enantiomers, including d-threo-methylphenidate. These patents reflect his dedication to addressing the complexities of medication administration.

Career Highlights

Throughout his career, Mathias Scheer has worked with renowned companies in the pharmaceutical sector. His experience at Develco Pharma Schweiz AG has allowed him to refine his skills in drug formulation and development. Furthermore, his tenure at Kremers Urban Pharmaceuticals, Inc. provided him with the opportunity to contribute to various innovative projects within the industry.

Collaborations

Collaboration plays a crucial role in innovation, and Mathias has had the privilege of working alongside distinguished colleagues such as Dirk Kramer and Hélène Rey. These partnerships have enabled him to leverage diverse expertise and drive forward-thinking initiatives in pharmaceutical research and development.

Conclusion

Mathias Scheer's contributions to the pharmaceutical industry through his innovative patents signify his vital role as an inventor. His work not only exemplifies the spirit of innovation but also promises to enhance patient care through advanced medication formulations. As the field of pharmaceuticals continues to evolve, inventors like Scheer pave the way for future advancements in treatment methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…